119 results, showing 1 to 20
On 18 December 2012 the ACCC accepted a section 87B undertaking from Oticon Australia Pty Ltd ("Oticon") who are engaged in the wholesale and retail sales of hearing instruments (hearing aids) in Australia.
On 12 December 2012, the ACCC consented to a variation of the section 87B Undertaking given by Pfizer Inc and Pfizer Australia Pty Ltd (together referred to as Pfizer) on 30 September 2009 (the Undertaking).
The ACCC accepted the Undertaking as part of its decision not to oppose Pfizer’s proposed acquisition of Wyeth Corp. Amongst other things, the Undertaking required the divestiture of Wyeth’s Fort Dodge Livestock Business to a purchaser approved by the ACCC (Virbac Group).
The Livestock Business comprised a number of pharmaceutical vaccines including the mycoplasma hypopneumoniae vaccine (M Hyo Swine Vaccines) which is manufactured overseas and imported into Australia for sale.
The Undertaking has been varied to remove the obligations relating to the transfer of the manufacture of the M Hyo Swine Vaccines to Virbac. Several clauses relating to the confidential obligations have also been varied.
The ACCC has accepted a section 87B Undertaking from Angela Delgiacco in respect of false or misleading representations made to consumers during the sale of an Indigenous artwork.
Angela Delgiacco admits that she contravened sections 18 and 29(I)(a) of the Competition and Consumer Act 2010 by, in relation to the painting titled 'Women's Hairstring Ceremony' (the Artwork), attributing:
a title to the Artwork which was commonly attributed to paintings by Makinti Napanangka rather than a title given to the Artwork by Makinti Napanangka; and
a date to the Artwork without knowledge of when the Artwork was painted.
Nissan Motor Co (Australia) Pty Ltd is a seller and distributor of motor vehicles and spare parts, and uses television and print advertising to promote its vehicles in Australia.
In response to an ACCC investigation into the publication of an advertisement for the Nissan DUALIS vehicle, Nissan admitted that it:
- engaged in conduct that was misleading or deceptive or was likely to mislead or deceive in contravention of section 18 of the Australian Consumer Law (ACL); and
On 22 November 2012, the ACCC announced it had accepted undertakings from Nestlé S.A, Nestlé Australia Pty Ltd and Duke Holdco Pty Ltd (together, Nestlé) (Nestlé Undertaking) and Pfizer Australia Pty Ltd (Pfizer Undertaking) in relation to Nestlé S.A’s proposed acquisition of Pfizer Nutrition (the Proposed Acquisition).
On 22 November 2012, the ACCC announced it had accepted undertakings from Nestlé S.A, Nestlé Australia Pty Ltd and Duke Holdco Pty Ltd (together, Nestlé) (Nestlé Undertaking) and Pfizer Australia Pty Ltd (Pfizer Undertaking) in relation to Nestlé S.A’s proposed acquisition of Pfizer Nutrition (the Proposed Acquisition).